News - Page 152 - Psychedelic Alpha

Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Read more about the article Psychedelic Bulletin: Are REMS Patents the Next Frontier in the Psychedelics Patent Skirmish? Johns Hopkins Researcher Scores U.S. Government Grant

Psychedelic Bulletin: Are REMS Patents the Next Frontier in the Psychedelics Patent Skirmish? Johns Hopkins Researcher Scores U.S. Government Grant

Post published:September 24, 2021
Post category:Psychedelic Bulletin

Read more about the article PharmaTher Announces CAD$10 Million Private Placement With Institutional Investors

PharmaTher Announces CAD$10 Million Private Placement With Institutional Investors

Post published:September 24, 2021
Post category:Press Release

Read more about the article Levitee Labs Announces DTC Eligibility Approval

Levitee Labs Announces DTC Eligibility Approval

Post published:September 24, 2021
Post category:Press Release

Read more about the article Awakn Life Sciences Acquires Exclusive Rights to MDMA Research from Imperial College London

Awakn Life Sciences Acquires Exclusive Rights to MDMA Research from Imperial College London

Post published:September 23, 2021
Post category:Press Release

Read more about the article Numinus Completes Acquisition of Neurology Centre of Toronto

Numinus Completes Acquisition of Neurology Centre of Toronto

Post published:September 23, 2021
Post category:Press Release

Read more about the article Wake Network, Inc. Receives Certificate of Drug Registration for Microdose Formulation in Jamaica

Wake Network, Inc. Receives Certificate of Drug Registration for Microdose Formulation in Jamaica

Post published:September 23, 2021
Post category:Press Release

Read more about the article MindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration

MindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration

Post published:September 23, 2021
Post category:Press Release

Read more about the article ATMA Journey Centers Offer Regulated Health Care Professionals a Means to Incorporate Psychedelic-Assisted Psychotherapy Into Their Practice

ATMA Journey Centers Offer Regulated Health Care Professionals a Means to Incorporate Psychedelic-Assisted Psychotherapy Into Their Practice

Post published:September 23, 2021
Post category:Press Release

Read more about the article MINDCURE Signs Exclusive Digital Clinical Data Licensing Agreement with ATMA Journey Centers

MINDCURE Signs Exclusive Digital Clinical Data Licensing Agreement with ATMA Journey Centers

Post published:September 23, 2021
Post category:Press Release

Read more about the article Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data

Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data

Post published:September 22, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.